{
  "title": "HIV Clinical Decision Support Report",
  "generated": "2025-12-26T04:01:55.762824",
  "sections": {
    "vaccine_development": {
      "timestamp": "2025-12-26T04:01:47.232349",
      "total_candidates": 387,
      "top_candidates": [
        {
          "epitope": "TPQDLNTML",
          "protein": "Gag",
          "priority_score": 0.97,
          "stability_score": 173.6570951669032,
          "population_coverage": 0.95,
          "manufacturability": 0.95
        },
        {
          "epitope": "YFPDWQNYT",
          "protein": "Nef",
          "priority_score": 0.8783511066512115,
          "stability_score": 133.86839368137342,
          "population_coverage": 0.95,
          "manufacturability": 0.95
        },
        {
          "epitope": "QVPLRPMTYK",
          "protein": "Nef",
          "priority_score": 0.8783511066512115,
          "stability_score": 133.86839368137342,
          "population_coverage": 0.95,
          "manufacturability": 0.95
        },
        {
          "epitope": "RAIEAQQHL",
          "protein": "Env",
          "priority_score": 0.8637143542008294,
          "stability_score": 121.00181282958846,
          "population_coverage": 0.95,
          "manufacturability": 1.0
        },
        {
          "epitope": "AAVDLSHFL",
          "protein": "Nef",
          "priority_score": 0.8483511066512116,
          "stability_score": 133.86839368137342,
          "population_coverage": 0.95,
          "manufacturability": 0.85
        },
        {
          "epitope": "YPLTFGWCF",
          "protein": "Nef",
          "priority_score": 0.8483511066512116,
          "stability_score": 133.86839368137342,
          "population_coverage": 0.95,
          "manufacturability": 0.85
        },
        {
          "epitope": "RPQVPLRPM",
          "protein": "Nef",
          "priority_score": 0.8458930954247681,
          "stability_score": 119.7769838201762,
          "population_coverage": 0.95,
          "manufacturability": 0.95
        },
        {
          "epitope": "RYPLTFGW",
          "protein": "Nef",
          "priority_score": 0.8296640898115464,
          "stability_score": 112.7312788895776,
          "population_coverage": 0.95,
          "manufacturability": 0.95
        },
        {
          "epitope": "TAFTIPSI",
          "protein": "Pol",
          "priority_score": 0.8252828307563003,
          "stability_score": 104.31704601904929,
          "population_coverage": 0.95,
          "manufacturability": 1.0
        },
        {
          "epitope": "RLRPGGKKKY",
          "protein": "Gag",
          "priority_score": 0.825,
          "stability_score": 104.19425710014193,
          "population_coverage": 0.95,
          "manufacturability": 1.0
        }
      ],
      "protein_distribution": {
        "Gag": 16,
        "Nef": 16,
        "Pol": 10,
        "Env": 3,
        "Vpr": 2,
        "Vif": 2,
        "Tat": 1
      },
      "recommendations": [
        "Primary candidate: TPQDLNTML from Gag (score: 0.970)",
        "Recommended combination: Include epitopes from Gag, Nef, and Pol for broad coverage"
      ]
    },
    "resistance_monitoring": {
      "timestamp": "2025-12-26T04:01:47.233857",
      "screening_summary": {
        "total_screened": 7154,
        "high_risk": 2489,
        "moderate_risk": 1218,
        "low_risk": 1732,
        "minimal_risk": 1715,
        "mean_risk_score": 0.5131873577036635
      },
      "high_risk_sequences": [
        {
          "sequence_id": 157,
          "risk_score": 1.0,
          "n_markers": 5,
          "markers": [
            "M36I",
            "L10I",
            "L10I",
            "I54V",
            "L10I"
          ]
        },
        {
          "sequence_id": 158,
          "risk_score": 1.0,
          "n_markers": 5,
          "markers": [
            "M36I",
            "L10I",
            "L10I",
            "I54V",
            "L10I"
          ]
        },
        {
          "sequence_id": 159,
          "risk_score": 1.0,
          "n_markers": 5,
          "markers": [
            "M36I",
            "L10I",
            "L10I",
            "I54V",
            "L10I"
          ]
        },
        {
          "sequence_id": 160,
          "risk_score": 1.0,
          "n_markers": 5,
          "markers": [
            "M36I",
            "L10I",
            "L10I",
            "I54V",
            "L10I"
          ]
        },
        {
          "sequence_id": 165,
          "risk_score": 1.0,
          "n_markers": 4,
          "markers": [
            "I54V",
            "L10I",
            "L10I",
            "A71V"
          ]
        },
        {
          "sequence_id": 171,
          "risk_score": 1.0,
          "n_markers": 5,
          "markers": [
            "I54V",
            "I54V",
            "L10I",
            "I54V",
            "I93L"
          ]
        },
        {
          "sequence_id": 172,
          "risk_score": 1.0,
          "n_markers": 5,
          "markers": [
            "I54V",
            "I54V",
            "L10I",
            "I54V",
            "I93L"
          ]
        },
        {
          "sequence_id": 173,
          "risk_score": 1.0,
          "n_markers": 5,
          "markers": [
            "I54V",
            "I54V",
            "L10I",
            "I54V",
            "I93L"
          ]
        },
        {
          "sequence_id": 278,
          "risk_score": 1.0,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L90M",
            "I54V"
          ]
        },
        {
          "sequence_id": 279,
          "risk_score": 1.0,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L90M",
            "I54V"
          ]
        },
        {
          "sequence_id": 282,
          "risk_score": 1.0,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L90M",
            "I54V"
          ]
        },
        {
          "sequence_id": 285,
          "risk_score": 0.9179727254223489,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L10I",
            "I54V"
          ]
        },
        {
          "sequence_id": 286,
          "risk_score": 1.0,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L90M",
            "I54V"
          ]
        },
        {
          "sequence_id": 288,
          "risk_score": 0.9179727254223489,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L10I",
            "I54V"
          ]
        },
        {
          "sequence_id": 289,
          "risk_score": 1.0,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L90M",
            "I54V"
          ]
        },
        {
          "sequence_id": 290,
          "risk_score": 1.0,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L90M",
            "I54V"
          ]
        },
        {
          "sequence_id": 291,
          "risk_score": 0.9179727254223489,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L10I",
            "I54V"
          ]
        },
        {
          "sequence_id": 294,
          "risk_score": 0.9179727254223489,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L10I",
            "I54V"
          ]
        },
        {
          "sequence_id": 295,
          "risk_score": 0.9179727254223489,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L10I",
            "I54V"
          ]
        },
        {
          "sequence_id": 296,
          "risk_score": 1.0,
          "n_markers": 3,
          "markers": [
            "I54V",
            "L90M",
            "I54V"
          ]
        }
      ],
      "mutation_frequency": {
        "I54V": 4627,
        "L10I": 1640,
        "L63P": 1533,
        "M36I": 1429,
        "I93L": 1419,
        "L90M": 970,
        "A71V": 828,
        "L33F": 734,
        "V82A": 514,
        "M46I": 2
      }
    },
    "host_directed_therapy": {
      "timestamp": "2025-12-26T04:01:48.392882",
      "summary": {
        "total_tat_interactions": 4027,
        "unique_human_targets": 1576,
        "high_druggability_targets": 247
      },
      "top_druggable_targets": [
        {
          "protein": "1-phosphatidylinositol 3-phosphate 5-kinase isoform 2",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "urokinase-type plasminogen activator isoform 1 preproprotein",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "vascular endothelial growth factor receptor 1 isoform 1 precursor",
          "family": "receptor",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "vascular endothelial growth factor receptor 2 precursor",
          "family": "receptor",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "TNF receptor-associated factor 3 isoform 1",
          "family": "receptor",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "TNF receptor-associated factor 4",
          "family": "receptor",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "bone morphogenetic protein receptor type-1A precursor",
          "family": "receptor",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "bone morphogenetic protein receptor type-1B isoform b precursor",
          "family": "receptor",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "bone morphogenetic protein receptor type-2 precursor",
          "family": "receptor",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "cAMP-dependent protein kinase catalytic subunit alpha isoform Calpha1",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "cAMP-dependent protein kinase catalytic subunit beta isoform 1",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "cAMP-dependent protein kinase catalytic subunit gamma",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "cAMP-dependent protein kinase type I-alpha regulatory subunit isoform a",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "cAMP-dependent protein kinase type I-beta regulatory subunit",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        },
        {
          "protein": "cAMP-dependent protein kinase type II-alpha regulatory subunit isoform a",
          "family": "kinase",
          "druggability": "high",
          "score": 1.0
        }
      ],
      "drug_opportunities": {
        "kinase_inhibitors": [
          {
            "protein": "1-phosphatidylinositol 3-phosphate 5-kinase isoform 2",
            "interaction_type": "inhibited by",
            "druggability_score": 1.0
          },
          {
            "protein": "urokinase-type plasminogen activator isoform 1 preproprotein",
            "interaction_type": "induces release of, upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "cAMP-dependent protein kinase catalytic subunit alpha isoform Calpha1",
            "interaction_type": "inhibits, activates, upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "cAMP-dependent protein kinase catalytic subunit beta isoform 1",
            "interaction_type": "inhibits, activates, upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "cAMP-dependent protein kinase catalytic subunit gamma",
            "interaction_type": "inhibits, activates, upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "cAMP-dependent protein kinase type I-alpha regulatory subunit isoform a",
            "interaction_type": "activates",
            "druggability_score": 1.0
          },
          {
            "protein": "cAMP-dependent protein kinase type I-beta regulatory subunit",
            "interaction_type": "activates",
            "druggability_score": 1.0
          },
          {
            "protein": "cAMP-dependent protein kinase type II-alpha regulatory subunit isoform a",
            "interaction_type": "activates",
            "druggability_score": 1.0
          },
          {
            "protein": "cAMP-dependent protein kinase type II-beta regulatory subunit",
            "interaction_type": "activates",
            "druggability_score": 1.0
          },
          {
            "protein": "cGMP-dependent protein kinase 1 isoform 2",
            "interaction_type": "interacts with",
            "druggability_score": 1.0
          },
          {
            "protein": "5'-AMP-activated protein kinase subunit gamma-3",
            "interaction_type": "induces phosphorylation of",
            "druggability_score": 1.0
          },
          {
            "protein": "3-phosphoinositide-dependent protein kinase 1 isoform 1",
            "interaction_type": "induces phosphorylation of",
            "druggability_score": 1.0
          },
          {
            "protein": "5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform 1",
            "interaction_type": "inhibits, regulated by, interacts with, induces phosphorylation of",
            "druggability_score": 1.0
          },
          {
            "protein": "5'-AMP-activated protein kinase catalytic subunit alpha-2",
            "interaction_type": "interacts with, induces phosphorylation of",
            "druggability_score": 1.0
          },
          {
            "protein": "5'-AMP-activated protein kinase subunit beta-1",
            "interaction_type": "interacts with, induces phosphorylation of",
            "druggability_score": 1.0
          },
          {
            "protein": "5'-AMP-activated protein kinase subunit gamma-1 isoform 1",
            "interaction_type": "activates, induces phosphorylation of",
            "druggability_score": 1.0
          },
          {
            "protein": "5'-AMP-activated protein kinase subunit gamma-2 isoform a",
            "interaction_type": "activates, induces phosphorylation of",
            "druggability_score": 1.0
          },
          {
            "protein": "serine/threonine-protein kinase pim-2",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "serine/threonine-protein kinase/endoribonuclease IRE1 precursor",
            "interaction_type": "induces",
            "druggability_score": 1.0
          },
          {
            "protein": "ATP-dependent 6-phosphofructokinase, platelet type isoform 1",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          }
        ],
        "receptor_antagonists": [
          {
            "protein": "vascular endothelial growth factor receptor 1 isoform 1 precursor",
            "interaction_type": "downregulates, cooperates with, activates, binds, inhibited by",
            "druggability_score": 1.0
          },
          {
            "protein": "vascular endothelial growth factor receptor 2 precursor",
            "interaction_type": "downregulates, activates, upregulates, interacts with, induces phosphorylation of, regulated by",
            "druggability_score": 1.0
          },
          {
            "protein": "TNF receptor-associated factor 3 isoform 1",
            "interaction_type": "downregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "TNF receptor-associated factor 4",
            "interaction_type": "inhibited by",
            "druggability_score": 1.0
          },
          {
            "protein": "bone morphogenetic protein receptor type-1A precursor",
            "interaction_type": "modulates",
            "druggability_score": 1.0
          },
          {
            "protein": "bone morphogenetic protein receptor type-1B isoform b precursor",
            "interaction_type": "modulates",
            "druggability_score": 1.0
          },
          {
            "protein": "bone morphogenetic protein receptor type-2 precursor",
            "interaction_type": "downregulates, inhibited by, modulates",
            "druggability_score": 1.0
          },
          {
            "protein": "calcitonin receptor isoform 2 precursor",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "5-hydroxytryptamine receptor 2B isoform 1",
            "interaction_type": "downregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "thyroid hormone receptor alpha isoform 2",
            "interaction_type": "synergizes with, binds",
            "druggability_score": 1.0
          },
          {
            "protein": "toll-like receptor 2 precursor",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "toll-like receptor 4 isoform A precursor",
            "interaction_type": "downregulates, engages, interacts with, upregulates, regulated by",
            "druggability_score": 1.0
          },
          {
            "protein": "toll-like receptor 9 precursor",
            "interaction_type": "downregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "toll/interleukin-1 receptor domain-containing adapter protein isoform a",
            "interaction_type": "degrades",
            "druggability_score": 1.0
          },
          {
            "protein": "transferrin receptor protein 1 isoform 1",
            "interaction_type": "interacts with",
            "druggability_score": 1.0
          },
          {
            "protein": "tumor necrosis factor receptor superfamily member 16 precursor",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "tumor necrosis factor receptor superfamily member 1A isoform 1 precursor",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "short transient receptor potential channel 1 isoform 2",
            "interaction_type": "interacts with",
            "druggability_score": 1.0
          },
          {
            "protein": "sigma non-opioid intracellular receptor 1 isoform 1",
            "interaction_type": "regulated by",
            "druggability_score": 1.0
          },
          {
            "protein": "substance-K receptor",
            "interaction_type": "downregulates",
            "druggability_score": 1.0
          }
        ],
        "protease_inhibitors": [
          {
            "protein": "plasma protease C1 inhibitor precursor",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          },
          {
            "protein": "apoptotic protease-activating factor 1 isoform b",
            "interaction_type": "upregulates",
            "druggability_score": 1.0
          }
        ],
        "other_targets": [
          {
            "protein": "zinc transporter 4 isoform 1",
            "interaction_type": "downregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "antigen peptide transporter 1 isoform 1",
            "interaction_type": "upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "all-trans-retinol dehydrogenase",
            "interaction_type": "upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "urea transporter 1 isoform 2",
            "interaction_type": "downregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "voltage-dependent calcium channel gamma-like subunit",
            "interaction_type": "downregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "NAD(P)H dehydrogenase",
            "interaction_type": "stabilized by, upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "M-phase inducer phosphatase 3 isoform a",
            "interaction_type": "downregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "ectonucleotide pyrophosphatase/phosphodiesterase family member 2 isoform 1 preproprotein",
            "interaction_type": "inhibits, interacts with, decreases",
            "druggability_score": 0.6
          },
          {
            "protein": "dual specificity protein phosphatase 4 isoform 1",
            "interaction_type": "upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "dual specificity protein phosphatase 1",
            "interaction_type": "upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial isoform 1 precursor",
            "interaction_type": "upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "L-lactate dehydrogenase B chain isoform LDHB",
            "interaction_type": "downregulates, upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "L-lactate dehydrogenase A chain isoform 1",
            "interaction_type": "downregulates, upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "glucose-6-phosphate 1-dehydrogenase isoform a",
            "interaction_type": "activates, upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "excitatory amino acid transporter 2 isoform 1",
            "interaction_type": "modulates",
            "druggability_score": 0.6
          },
          {
            "protein": "inosine-5'-monophosphate dehydrogenase 2",
            "interaction_type": "upregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "glyceraldehyde-3-phosphate dehydrogenase isoform 1",
            "interaction_type": "interacts with",
            "druggability_score": 0.6
          },
          {
            "protein": "inward rectifier potassium channel 13 isoform 1",
            "interaction_type": "downregulates",
            "druggability_score": 0.6
          },
          {
            "protein": "nuclear inhibitor of protein phosphatase 1 isoform alpha",
            "interaction_type": "inhibited by, binds",
            "druggability_score": 0.6
          },
          {
            "protein": "monocarboxylate transporter 12",
            "interaction_type": "downregulates",
            "druggability_score": 0.6
          }
        ]
      },
      "recommendations": [
        "Consider repurposing existing kinase inhibitors - 20 kinase targets identified",
        "Receptor-based therapies promising - 20 receptor targets identified",
        "Host-directed therapy via Tat targets avoids viral resistance evolution"
      ]
    }
  },
  "executive_summary": [
    "TOP VACCINE CANDIDATE: TPQDLNTML from Gag (priority score: 0.970)",
    "MDR ALERT: 2489 high-risk sequences detected (34.8% of screened population)",
    "DRUG TARGETS: 247 high-druggability Tat targets identified for host-directed therapy development"
  ],
  "action_items": [
    {
      "priority": "HIGH",
      "category": "Resistance Monitoring",
      "action": "Implement L63P/L90M screening in clinical genotyping",
      "rationale": "79.5% of MDR cases carry L63P mutation"
    },
    {
      "priority": "MEDIUM",
      "category": "Vaccine Development",
      "action": "Advance TPQDLNTML to preclinical",
      "rationale": "Highest stability score + population coverage"
    },
    {
      "priority": "RESEARCH",
      "category": "Drug Development",
      "action": "Screen 20 kinase inhibitors for Tat disruption",
      "rationale": "Host-directed approach avoids resistance"
    }
  ]
}